Spark Therapeutics, Inc.
(NASDAQ : ONCE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.10%171.561.3%$500.63m
BIIBBiogen Inc.
1.48%236.361.3%$486.35m
CELGCelgene Corporation
0.22%96.461.3%$469.64m
GILDGilead Sciences, Inc.
0.25%66.690.9%$453.31m
ILMNIllumina, Inc.
2.17%313.123.5%$316.51m
REGNRegeneron Pharmaceuticals, Inc.
2.94%319.072.6%$292.87m
AAgilent Technologies, Inc.
-0.18%68.201.6%$199.60m
VRTXVertex Pharmaceuticals Incorporated
2.68%173.651.9%$182.34m
EXASExact Sciences Corporation
-1.38%95.6125.3%$168.46m
ALXNAlexion Pharmaceuticals, Inc.
-0.61%128.012.0%$150.52m
BMRNBioMarin Pharmaceutical Inc.
0.89%88.254.3%$118.75m
SRPTSarepta Therapeutics, Inc.
0.94%122.3314.7%$116.57m
INCYIncyte Corporation
0.89%79.382.5%$107.69m
IONSIonis Pharmaceuticals, Inc.
-0.95%68.588.2%$98.40m
ALNYAlnylam Pharmaceuticals, Inc
0.90%68.489.2%$96.47m

Company Profile

Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.